Concepedia

Lei Dou

LD

Statistics

Publications

3

Citations

79

H-Index

3

Active since

2022

Affiliations

Shandong University(Current)

Lei Dou is an author at Shandong University specializing in cost-effectiveness comparison, model-based economic evaluation, and cost-effectiveness analysis perspective.

Publications per year

2022–2023

3

Publications

3

Cost-effectiveness analysis of nivolumab combination therapy in the first-line treatment for advanced esophageal squamous-cell carcinoma

Shixian Liu, Lei Dou, Kaixuan Wang et al. · Frontiers in Oncology · 2022 · 29 citations · Full text

, , +17

Cost-effectiveness analysis of serplulimab plus chemotherapy in the first-line treatment for PD-L1-positive esophageal squamous cell carcinoma in China

Shixian Liu, Nana Jiang, Lei Dou et al. · Frontiers in Immunology · 2023 · 28 citations · Full text

, , +17

Cost-effectiveness analysis of PD-1 inhibitors combined with chemotherapy as first-line therapy for advanced esophageal squamous-cell carcinoma in China

Shixian Liu, Lei Dou, Shunping Li · Frontiers in Pharmacology · 2023 · 22 citations · Full text

, , +17

1–3 of 3